Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)

Phase Distribution

Ph not_applicable
2
67%
Ph phase_2
1
33%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(3)

Detailed Status

Completed3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (33.3%)
N/A2 (66.7%)

Trials by Status

completed3100%

Recent Activity

0 active trials
Showing 3 of 3
completedphase_2

Almond Butter and Fasting Glucose

NCT03826472
completednot_applicable

Postprandial Response to Almond Consumption in Overweight Hispanic Pregnant Women

NCT01919476
completednot_applicable

The Effect of Processing on the Measured Energy Value of Almonds in the Human Diet

NCT02034383

Clinical Trials (3)

Showing 3 of 3 trials
NCT03826472Phase 2

Almond Butter and Fasting Glucose

Completed
NCT01919476Not Applicable

Postprandial Response to Almond Consumption in Overweight Hispanic Pregnant Women

Completed
NCT02034383Not Applicable

The Effect of Processing on the Measured Energy Value of Almonds in the Human Diet

Completed

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3